Literature DB >> 15621789

Changes in leukemic cell nuclei revealed by differential scanning calorimetry.

Małgorzata Rogalińska1, Paweł Góralski, Agnieszka Kobylińska, Jerzy Z Błoński, Margaret Hanausek, Zbigniew Walaszek, Henryk Piekarski, Tadeusz Robak, Zofia M Kiliańska.   

Abstract

Using differential scanning calorimetry we analyzed the thermal profiles of nuclei from normal and B-cell chronic lymphocytic leukemia mononuclear cells. Intact nuclear fraction of normal mononuclear cells is characterized by four thermal transitions, i.e., at 60, 70, 83 and 103 degrees C. Leukemic nuclear samples revealed the transitions at 67 and 83 degrees C, however, in more aggressive stage of the disease additional thermal peaks at 76 and 93 degrees C were observed. Our very preliminary results revealed that mononuclear cell nuclear fraction from blood of patients responding to the used therapy, i.e., cladribine alone or its combination with mitoxantrone and cyclophosphamide indicates decrease (or even loss) of transition at 93 degrees C concomitant with increase of transition at 76 degrees C. A complementary study showed that in mononuclear cells of patients who appeared to be sensitive to chemotherapy the decrease of antiapoptotic Bcl-2 protein expression and signs of apoptotic morphology were observed.

Entities:  

Mesh:

Year:  2005        PMID: 15621789     DOI: 10.1080/10428190412331283170

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

1.  Toward personalized therapy for chronic lymphocytic leukemia: DSC and cDNA microarray assessment of two cases.

Authors:  Małgorzata Rogalińska; Ida Franiak-Pietryga; Jerzy Z Błoński; Paweł Góralski; Henryk Maciejewski; Agnieszka Janus; Paweł Robak; Marek Mirowski; Henryk Piekarski; Tadeusz Robak; Zofia M Kiliańska
Journal:  Cancer Biol Ther       Date:  2012-10-31       Impact factor: 4.742

2.  Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development.

Authors:  Małgorzata Rogalińska; Paweł Góralski; Jerzy Z Błoński; Paweł Robak; Jan Barciszewski; Aneta Koceva-Chyła; Henryk Piekarski; Tadeusz Robak; Zofia M Kilianska
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.